The United States has approved its first-ever over-the-counter birth control pill, allowing women to purchase the daily oral contraceptive without a doctor’s prescription. Marketed under the brand “Opill,” the pill will be available in pharmacies nationwide starting August.
Health experts hailed the move as a significant step toward reproductive freedom, especially for low-income women or those living in remote areas. However, some conservative groups criticized the lack of mandatory medical consultation.
This news may resonate in South Asian contexts, where access to reproductive healthcare varies. The development could reignite debates on expanding women’s healthcare rights in countries like Bangladesh and India.
